APA (7th ed.) Citation

Tummala, R., Abreu, G., Pineda, L., Michaels, M. A., Kalyani, R. N., Furie, R. A., & Morand, E. F. (2021). Safety profile of anifrolumab in patients with active SLE: An integrated analysis of phase II and III trials. Lupus science & medicine, 8(1), e000464. https://doi.org/10.1136/lupus-2020-000464

Chicago Style (17th ed.) Citation

Tummala, Raj, Gabriel Abreu, Lilia Pineda, M Alex Michaels, Rubana N. Kalyani, Richard A. Furie, and Eric F. Morand. "Safety Profile of Anifrolumab in Patients with Active SLE: An Integrated Analysis of Phase II and III Trials." Lupus Science & Medicine 8, no. 1 (2021): e000464. https://doi.org/10.1136/lupus-2020-000464.

MLA (9th ed.) Citation

Tummala, Raj, et al. "Safety Profile of Anifrolumab in Patients with Active SLE: An Integrated Analysis of Phase II and III Trials." Lupus Science & Medicine, vol. 8, no. 1, 2021, p. e000464, https://doi.org/10.1136/lupus-2020-000464.